Table 1.
HDAC classes and their inhibitors.
| HDAC Class | Member | Subcellular Localization | Tissue Distribution | Inhibitors |
|---|---|---|---|---|
| Class I | HDAC 1 | Nucleus | Ubiquitous | SAHA, TSA, Entinostat (MS-275), Crebinostat, Valproic acid, compound 60, Fingolimod, Mocetinostat |
| HDAC 2 | Nucleus | Ubiquitous | SAHA, TSA, Entinostat (MS-275), Crebinostat, Valproic acid, Compound 60, Fingolimod, Apicidin | |
| HDAC 3 | Nucleus | Ubiquitous | SAHA, TSA, Entinostat (MS-275), Crebinostat, Valproic acid, Fingolimod, Apicidin, | |
| HDAC 8 | Nucleus, Cytoplasm | Mostly Ubiquitous | Valproic acid, Fingolimod, NBM-T-L-BMX-OS01 | |
| Class IIa | HDAC 4 | Nucleus, Cytoplasm | Brain, Heart, Skeletal Muscle | SAHA, Trichostatin A, Sodium Butyrate, MC1568 |
| HDAC 5 | Nucleus, Cytoplasm | Brain, Heart, Skeletal Muscle | SAHA, 4-Phenylbutyrate | |
| HDAC 7 | Nucleus, Cytoplasm, Mitochondria | Heart, Skeletal Muscle, Placenta | SAHA | |
| HDAC 9 | Nucleus, Cytoplasm | Brain, Skeletal Muscle | SAHA | |
| Class IIb | HDAC 6 | Predominantly cytoplasm | Heart, Liver, Placenta, Kidney | SAHA, Crebinostat, Tubacin, Tubastatin A, ACY-738, ACY-775 |
| HDAC 10 | Predominantly cytoplasm | Liver, Kidney, Spleen | Tubastatin A, Bufexamac | |
| Class III | Mammalian sirtuins (SIRT1-7) | Nucleus, Cytoplasm, Mitochondria | Fetal brain>adult brain (except SIRT 2 &5). SIRT4 highly expressed in astrocytes (postnatal brain) & in radial glia (embryonic tissues) | Resveratrol, Suramin, Nicotinamide, SRT1720, SRT3657 |
| Class IV | HDAC 11 | Nucleus, Cytoplasm | Brain, Heart, Kidney, Skeletal Muscle | Trichostatin A |
SAHA: Vorinostat; Fingolimod: phosphorylated-FTY720; TSA: Trichostatin A
(Volmar and Wahlestedt, 2014; Dokmanovic et al., 2007; de Ruijter et al., 2003)